InvestorsHub Logo
Followers 199
Posts 17209
Boards Moderated 2
Alias Born 02/17/2012

Re: None

Wednesday, 08/05/2020 1:46:01 PM

Wednesday, August 05, 2020 1:46:01 PM

Post# of 28
PR: “ALX Oncology Presents Preliminary Phase 1 Study Results of ALX148 in Combination with Rituximab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma”

https://ir.alxoncology.com/node/6471


What we've got here...is failure to communicate. Some men you just can't reach...which is the way he wants it, well, HE GETS IT! And I dont like it anymore than you men.

*Contact your licensed financial advisor before entering the market.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALXO News